Advanced search
1 file | 1.04 MB Add to list

Intravenous immunoglobulins modify relapsing membranous glomerulonephritis after kidney transplantation : a case report

Sanne Steyaert, Jo Van Dorpe (UGent) , Anne Hoorens (UGent) , Wim Van Biesen (UGent) and Steven Van Laecke (UGent)
(2018) ACTA CLINICA BELGICA. 73(3). p.229-232
Author
Organization
Abstract
OBJECTIVES: Recurrence of membranous glomerulonephritis after transplant is common and is an important cause of loss of renal graft. This case supports the effect of immunoglobulins in the treatment of this disease after transplantation. It is the first report in the literature with a follow-up of more than 10 years and because of the sustained effect of the immunoglobulins, it strengthens the idea that this can alter long-term outcome. METHODS: Single case study and search of the literature. RESULTS: A female transplant recipient, who had an early histologically proven relapse of an idiopathic membranous glomerulonephritis and who was, before transplantation, refractory to various immunosuppressive agents. This relapsing disease has now been stable for over 10 years of intravenous immunoglobulins treatment in conjunction with belatacept and low doses of corticosteroids after gradual withdrawal of mycophenolate mofetil. This report supports the finding that immunoglobulins could influence the course of a relapse of membranous glomerulonephritis after transplantation. CONCLUSION: This case illustrates that immunoglobulins had long-lasting effects on the renal transplant although the glomerulonephritis had been resistant to other lines of therapy before transplant. We advocate that the use of immunoglobulins as a rescue therapy in refractory idiopathic membranous glomerulonephritis should be further investigated. Presently, existing evidence only comes from retrospective data and non-randomized trials.
Keywords
APLA2R, anti-phospholipase 2-receptor antibodies, CD80, podocytic B7–1 protein, CTLA-4, cytotoxic T-lymphocyte-associated antigen 4, FSGS, focal segmental glomerulosclerosis, GBMs, glomerular basement membranes, HLA, human leukocyte antigen, IMGN, membranous glomerulonephritis, IVIG, intravenous gamma-globulins, Immunoglobulins, MMF, mycophenolate mofetil, kidney transplant, membranous nephropathy, relapsing, NEPHROPATHY, THERAPY

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.04 MB

Citation

Please use this url to cite or link to this publication:

MLA
Steyaert, Sanne, Jo Van Dorpe, Anne Hoorens, et al. “Intravenous Immunoglobulins Modify Relapsing Membranous Glomerulonephritis After Kidney Transplantation : a Case Report.” ACTA CLINICA BELGICA 73.3 (2018): 229–232. Print.
APA
Steyaert, Sanne, Van Dorpe, J., Hoorens, A., Van Biesen, W., & Van Laecke, S. (2018). Intravenous immunoglobulins modify relapsing membranous glomerulonephritis after kidney transplantation : a case report. ACTA CLINICA BELGICA, 73(3), 229–232.
Chicago author-date
Steyaert, Sanne, Jo Van Dorpe, Anne Hoorens, Wim Van Biesen, and Steven Van Laecke. 2018. “Intravenous Immunoglobulins Modify Relapsing Membranous Glomerulonephritis After Kidney Transplantation : a Case Report.” Acta Clinica Belgica 73 (3): 229–232.
Chicago author-date (all authors)
Steyaert, Sanne, Jo Van Dorpe, Anne Hoorens, Wim Van Biesen, and Steven Van Laecke. 2018. “Intravenous Immunoglobulins Modify Relapsing Membranous Glomerulonephritis After Kidney Transplantation : a Case Report.” Acta Clinica Belgica 73 (3): 229–232.
Vancouver
1.
Steyaert S, Van Dorpe J, Hoorens A, Van Biesen W, Van Laecke S. Intravenous immunoglobulins modify relapsing membranous glomerulonephritis after kidney transplantation : a case report. ACTA CLINICA BELGICA. 2018;73(3):229–32.
IEEE
[1]
S. Steyaert, J. Van Dorpe, A. Hoorens, W. Van Biesen, and S. Van Laecke, “Intravenous immunoglobulins modify relapsing membranous glomerulonephritis after kidney transplantation : a case report,” ACTA CLINICA BELGICA, vol. 73, no. 3, pp. 229–232, 2018.
@article{8529385,
  abstract     = {OBJECTIVES: Recurrence of membranous glomerulonephritis after transplant is common and is an important cause of loss of renal graft. This case supports the effect of immunoglobulins in the treatment of this disease after transplantation. It is the first report in the literature with a follow-up of more than 10 years and because of the sustained effect of the immunoglobulins, it strengthens the idea that this can alter long-term outcome.
METHODS: Single case study and search of the literature.
RESULTS: A female transplant recipient, who had an early histologically proven relapse of an idiopathic membranous glomerulonephritis and who was, before transplantation, refractory to various immunosuppressive agents. This relapsing disease has now been stable for over 10 years of intravenous immunoglobulins treatment in conjunction with belatacept and low doses of corticosteroids after gradual withdrawal of mycophenolate mofetil. This report supports the finding that immunoglobulins could influence the course of a relapse of membranous glomerulonephritis after transplantation.
CONCLUSION: This case illustrates that immunoglobulins had long-lasting effects on the renal transplant although the glomerulonephritis had been resistant to other lines of therapy before transplant. We advocate that the use of immunoglobulins as a rescue therapy in refractory idiopathic membranous glomerulonephritis should be further investigated. Presently, existing evidence only comes from retrospective data and non-randomized trials.},
  author       = {Steyaert, Sanne and Van Dorpe, Jo and Hoorens, Anne and Van Biesen, Wim and Van Laecke, Steven},
  issn         = {1784-3286},
  journal      = {ACTA CLINICA BELGICA},
  keywords     = {APLA2R,anti-phospholipase 2-receptor antibodies,CD80,podocytic B7–1 protein,CTLA-4,cytotoxic T-lymphocyte-associated antigen 4,FSGS,focal segmental glomerulosclerosis,GBMs,glomerular basement membranes,HLA,human leukocyte antigen,IMGN,membranous glomerulonephritis,IVIG,intravenous gamma-globulins,Immunoglobulins,MMF,mycophenolate mofetil,kidney transplant,membranous nephropathy,relapsing,NEPHROPATHY,THERAPY},
  language     = {eng},
  number       = {3},
  pages        = {229--232},
  title        = {Intravenous immunoglobulins modify relapsing membranous glomerulonephritis after kidney transplantation : a case report},
  url          = {http://dx.doi.org/10.1080/17843286.2017.1361622},
  volume       = {73},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: